Category: News
BERGENBIO ASA: Minutes from the Annual General Meeting
March 19, 2021
Bergen, Norway, 19 March 2021 – Annual General Meeting in BerGenBio ASA (OSE:BGBIO) was virtually held on…
Read MoreBERGENBIO PRESENTS PRECLINICAL COVID-19 DATA AT ANNUAL CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS (CROI 2021)
March 6, 2021
Bergen, Norway, 6 March 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL…
Read MoreBERGENBIO CLOSES RECRUITMENT INTO TRIAL ASSESSING BEMCENTINIB IN COVID-19 PATIENTS
March 4, 2021
Bergen, Norway, 4th March 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL…
Read MoreBERGENBIO ASA: ANNUAL REPORT 2020
February 25, 2021
Bergen, Norway, 25 February 2021 – Reference is made to the notice on 23 February 2021 and the…
Read MoreRadium Podcast interview with BerGenBio CEO Richard Godfrey, hosted by RADFORSK
February 17, 2021
Bergen, Norway, 17 February 2021 - In this Radium podcast interview with RADFORSK, BerGenBio CEO Richard Godfrey…
Read MoreBERGENBIO ASA: RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2020
February 10, 2021
Bergen, Norway, 10 February 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for…
Read More
